Balyasny Asset Management
QTTB icon

Balyasny Asset Management’s Q32 Bio QTTB Stock Holding History

Balyasny Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+12,342
New +$103K ﹤0.01% 2852
2022
Q4 		– Sell
-777
Closed -$23K – 3307
2022
Q3 		$23K Buy
777
+115
+17% +$4.69K ﹤0.01% 2567
2022
Q2 		$23K Buy
+662
New +$22.6K ﹤0.01% 2461
2020
Q2 		– Sell
-2,689
Closed -$752K – 1549
2020
Q1 		$752K Sell
2,689
-1,269
-32% -$389K 0.01% 824
2019
Q4 		$1.48M Buy
+3,958
New +$1.13M 0.01% 813

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management's QTTB Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Q32 Bio (QTTB) in Q2 2026: 12,342 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #2852 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in QTTB as recently as Q3 2022.

Balyasny Asset Management first reported a position in QTTB in Q4 2019 and has held it in 5 quarters since. The position peaked at $1.48M in Q4 2019. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Balyasny Asset Management held 12,342 shares of Q32 Bio worth $157K as of Q2 2026.
  • Q32 Bio was a new Balyasny Asset Management position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2852 holding.
  • Balyasny Asset Management first reported a position in Q32 Bio in Q4 2019 and has held it in 5 quarters since.
  • Balyasny Asset Management's Q32 Bio position peaked at $1.48M in Q4 2019.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.